ROYAL BANK OF CANADA - CONTRAVIR PHARMACEUTICALS IN ownership

CONTRAVIR PHARMACEUTICALS IN's ticker is CTRVXXXX and the CUSIP is 21234W103. A total of 30 filers reported holding CONTRAVIR PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of CONTRAVIR PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2018$0560.0%0.00%
Q4 2017$0560.0%0.00%
Q3 2017$056
-90.7%
0.00%
Q2 2017$0
-100.0%
601
-45.0%
0.00%
Q1 2017$2,000
+100.0%
1,093
+121.7%
0.00%
Q4 2016$1,0000.0%4930.0%0.00%
Q3 2016$1,0000.0%4930.0%0.00%
Q2 2016$1,0000.0%4930.0%0.00%
Q1 2016$1,000
-75.0%
493
-80.2%
0.00%
Q4 2015$4,000
+300.0%
2,493
+405.7%
0.00%
Q3 2015$1,000
-66.7%
4930.0%0.00%
Q2 2015$3,000
+50.0%
4930.0%0.00%
Q1 2015$2,0004930.00%
Other shareholders
CONTRAVIR PHARMACEUTICALS IN shareholders Q1 2018
NameSharesValueWeighting ↓
EAM Investors, LLC 670,593$3,401,0000.45%
Prospera Financial Services Inc 184,100$236,0000.05%
HighTower Advisors, LLC 1,047,731$1,257,0000.01%
TWO SIGMA SECURITIES, LLC 15,142$18,0000.01%
TEACHERS ADVISORS, LLC 298,781$1,820,0000.00%
TIAA CREF INVESTMENT MANAGEMENT LLC 724,455$4,412,0000.00%
Virtu KCG Holdings LLC 90,490$109,0000.00%
FIRST FOUNDATION ADVISORS 10,000$12,0000.00%
Acrospire Investment Management LLC 2,300$3,0000.00%
Balentine LLC 55$00.00%
View complete list of CONTRAVIR PHARMACEUTICALS IN shareholders